OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Utility of the Specialized Pro-Resolving Mediators as Diagnostic and Prognostic Biomarkers in Disease
Jesmond Dalli, Esteban A. Gómez, Charlotte Jouvène
Biomolecules (2022) Vol. 12, Iss. 3, pp. 353-353
Open Access | Times Cited: 12
Jesmond Dalli, Esteban A. Gómez, Charlotte Jouvène
Biomolecules (2022) Vol. 12, Iss. 3, pp. 353-353
Open Access | Times Cited: 12
Showing 12 citing articles:
The role of efferocytosis‐fueled macrophage metabolism in the resolution of inflammation
Maaike Schilperoort, David Ngai, Santosh R. Sukka, et al.
Immunological Reviews (2023) Vol. 319, Iss. 1, pp. 65-80
Closed Access | Times Cited: 61
Maaike Schilperoort, David Ngai, Santosh R. Sukka, et al.
Immunological Reviews (2023) Vol. 319, Iss. 1, pp. 65-80
Closed Access | Times Cited: 61
Resolution pharmacology and the treatment of infectious diseases
Vivian Vasconcelos Costa, Filipe Resende, Eliza Mathias Melo, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 7, pp. 917-937
Open Access | Times Cited: 9
Vivian Vasconcelos Costa, Filipe Resende, Eliza Mathias Melo, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 7, pp. 917-937
Open Access | Times Cited: 9
Semaphorin3B promotes an anti-inflammatory and pro-resolving phenotype in macrophages from rheumatoid arthritis patients in a MerTK-dependent manner
Sara Martínez-Ramos, Carlos Rafael‐Vidal, Beatriz Malvar‐Fernández, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 4
Sara Martínez-Ramos, Carlos Rafael‐Vidal, Beatriz Malvar‐Fernández, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 4
Omega-3 (n-3) Fatty Acid–Statin Interaction: Evidence for a Novel Therapeutic Strategy for Atherosclerotic Cardiovascular Disease
Ivana Djuričić, Philip C. Calder
Nutrients (2024) Vol. 16, Iss. 7, pp. 962-962
Open Access | Times Cited: 4
Ivana Djuričić, Philip C. Calder
Nutrients (2024) Vol. 16, Iss. 7, pp. 962-962
Open Access | Times Cited: 4
Species-specific optimization of oxylipin ionization in LC–MS: a design of experiments approach to improve sensitivity
Louis Schmidt, Ulrike Garscha
Analytical and Bioanalytical Chemistry (2025)
Open Access
Louis Schmidt, Ulrike Garscha
Analytical and Bioanalytical Chemistry (2025)
Open Access
Oxylipins as canine sepsis indicators in vivo and in ex vivo skin organ culture model
Denise Biagini, Chiara Di Franco, Giulia Lazzarini, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Denise Biagini, Chiara Di Franco, Giulia Lazzarini, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Urinary lipid production in dogs with urothelial carcinoma
Akane Hayashi, Shingo Maeda, Arisa Yamazaki, et al.
The Veterinary Journal (2025) Vol. 313, pp. 106373-106373
Open Access
Akane Hayashi, Shingo Maeda, Arisa Yamazaki, et al.
The Veterinary Journal (2025) Vol. 313, pp. 106373-106373
Open Access
Lipoxin A4yields an electrophilic 15-oxo metabolite that mediates FPR2 receptor-independent anti-inflammatory signaling
Adolf Koudelka, Gregory J. Buchan, Veronika Cechova, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Adolf Koudelka, Gregory J. Buchan, Veronika Cechova, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Osteopathic manipulative treatment for chronic inflammatory diseases
Ross Gillan, Gabrielle Bachtel, Kassidy Webber, et al.
Journal of Evidence-Based Medicine (2024) Vol. 17, Iss. 1, pp. 172-186
Closed Access | Times Cited: 1
Ross Gillan, Gabrielle Bachtel, Kassidy Webber, et al.
Journal of Evidence-Based Medicine (2024) Vol. 17, Iss. 1, pp. 172-186
Closed Access | Times Cited: 1
Lipoxin A4 yields an electrophilic 15-oxo metabolite that mediates FPR2 receptor-independent anti-inflammatory signaling
Adolf Koudelka, Gregory J. Buchan, Veronika Cechova, et al.
Journal of Lipid Research (2024), pp. 100705-100705
Open Access | Times Cited: 1
Adolf Koudelka, Gregory J. Buchan, Veronika Cechova, et al.
Journal of Lipid Research (2024), pp. 100705-100705
Open Access | Times Cited: 1
Chronic back pain as a spinal osteoarthritis manifestation: rationale and practice of symptomatic slow acting drugs for osteoarthritis use
А. Е. Каратеев
Modern Rheumatology Journal (2022) Vol. 16, Iss. 4, pp. 88-97
Open Access | Times Cited: 6
А. Е. Каратеев
Modern Rheumatology Journal (2022) Vol. 16, Iss. 4, pp. 88-97
Open Access | Times Cited: 6
Maresin1 can be a potential therapeutic target for nerve injury
Xichen Wang, Benson O. A. Botchway, Yong Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114466-114466
Open Access | Times Cited: 2
Xichen Wang, Benson O. A. Botchway, Yong Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114466-114466
Open Access | Times Cited: 2
